Cell proliferation in salivary gland tumors;Proliferación celular en tumores de glándulas salivales

Acta Otorrinolaringologica Espanola

Volumn 52, Issue 6, 2001, Pages 456-460

  Frade González, Carlos ^a   Garcia Caballero T ^a   Lozano Ramirez A ^a   Labella Caballero, T ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Cell proliferation rates; MIB1; Salivary gland tumors

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PLEOMORPHIC ADENOMA; SALIVARY GLAND; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA; CELL DIVISION; PATHOLOGY;

CELL DIVISION; HUMANS; SALIVARY GLAND NEOPLASMS;

EID: 0035432916     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-6519(01)78236-2     Document Type: Article

References (24)

1. a edición, 1991.
2. Heck MMS, Earnshaw WC. Topoisomerase II: A specific marker for cell proliferation. J Cell Biol 1986; 103: 2569-2581.
3. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM. Monoclonal antibodies to nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 1987; 168: 475-486.
4. Clevenger CV, Epstein AL, Bauer KD. Modulation of the nuclear antigen p105 as a function of cell-cycle progression. J Cell Physiol 1987; 130: 336-343.
5. Garrido MC, Cordell JL, Becker MHG, et al. Monoclonal antibody JC1: new reagent for studying cell proliferation. J Clin Pathol 1992; 45: 860-865.
6. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-873.
7. Key G, Becker MHG, Baron B, Duchrow M, Schlüter C, Flad HD, Gerdes J. New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993; 68(6): 629-636.
8. Hamper K, Schimmelpenning H, Caselitz J, et al. Mucoepidermoid tumors of the salivary glands. Correlation of cytophotometrical data and prognosis. Cancer 1989; 63: 708-717.
9. Morgan DW, Crocker J, Watts A, Shenoi PM. Salivary gland tumours studied by means of the AgNOR technique. Histopathology 1988; 13: 553-559.
10. Murakami M, Ohtani I, Hojo H, Wakasa H. Immunohistochemical evaluation with Ki-67: An application to salivary gland tumours. J Laryngol Otol 1992; 106: 35-38.
11. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993; 22: 355-360.
12. Skálová A, Lehtonen H, Von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivar gland: Clinicopathological study using MIB1 antibody in paraffin sections. Hum Pathol 1994; 25: 929-935.
13. Skálová A, Leivo I, Von Boguslawsky K, Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using MIB1 antibody in formalin-fixed paraffin sections. J Pathol 1994; 173: 13-21.
14. Giannoni C, El-Naggar AK, Ordoñez NG, Tu ZN, Austin J, Luna MA, Batsakis JG. C-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms. Otolaryngol Head Neck Surg 1995; 112: 391-398.
15. Skálová A, Leivo I. Cell proliferation in salivary gland tumors. Gen Diagn Pathol 1996; 142: 7-16.
16. Nordgard S, Franzén G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997; 107: 531-536.
17. Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M, Viale G. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expresion and of in situ end labelling (Tunel). J Pathol 1997; 181: 323-329.
18. Michal M, Skalova A, Simpson RHW, Leivo I, Ryska A, Starek I. Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Hum Pathol 1997; 28: 595-600.
19. Fonseca I, Félix A, Soares J. Cell proliferation in salivary gland adenocarcinomas with myoepithelial participation. A study of 78 cases. Virchows Arch 1997; 430(3): 227-232.
20. Hyrabayashi S. Immunohistochemical detection of DNA topoisomerase type II alpha and Ki-67 in adenoid cystic carcinoma and pleomorphic adenoma of the salivar gland. J Oral Pathol Med 1999; 28(3): 131-136.
21. McCormick D, Yu C, Hobbs C, Hall PA. The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 1993; 22: 543-547.
22. Verheijen R, Kuijpers HJH, Van Driel R, Beck JL, Van Dierendonck JH, Brakenhoff GJ, Ramaekers FC. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Location in mitotic cells and association with chromosomes. J Cell Sci 1989; 92: 531-540.
23. Evans HL. Mucoepidermoid carcinomas of salivary glands: A study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984; 81: 696-701.
24. Batsakis JG. Staging os salivary gland neoplasms: role of histopathologic and molecular factors. Am J Surg 1994; 168: 386-390.